BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29925726)

  • 1. Methotrexate-associated lymphoproliferative disorder complicated by severe acute respiratory failure and ileal perforation:a case report.
    Suzuki E; Kanno T; Kimura S; Irie T; Odajima H; Migita K
    Fukushima J Med Sci; 2018 Aug; 64(2):82-88. PubMed ID: 29925726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
    Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N
    World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Three cases of methotrexate-associated lymphoproliferative disorder (MTX-LPD)].
    Ishida Y; Asahi A; Wada T; Kanai N; Kobayashi Y; Moriai S; Kishibe K; Harabuchi Y
    Nihon Jibiinkoka Gakkai Kaiho; 2008 Aug; 111(8):594-8. PubMed ID: 18788425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
    Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
    Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A methotrexate-associated lympholiferative disorder patient with gastrointestinal perforation].
    Aota Y; Nonaka T; Kimura S; Honda T; Okuda Y; Watanabe T; Fujiwara K; Yokoyama T; Wakabayashi Y; Sakurai M; Gotoh A
    Nihon Ronen Igakkai Zasshi; 2017; 54(4):567-572. PubMed ID: 29213000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.
    Matsumoto R; Numata K; Doba N; Hara K; Chuma M; Fukuda H; Nozaki A; Tanaka K; Ishii Y; Maeda S
    J Med Ultrason (2001); 2016 Oct; 43(4):545-51. PubMed ID: 27577564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-related lymphoproliferative disorder of the lumbar spine origin presenting with severe low-back pain: case report.
    Kikuchi N; Uesugi M; Koda M; Shimizu T; Murakami K; Kono M; Tanaka H; Yamazaki M
    J Neurosurg Spine; 2018 Nov; 29(5):545-548. PubMed ID: 30168781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
    Ikeda K; Nakamura T; Kinoshita T; Fujiwara M; Uose S; Someda H; Miyoshi T; Io K; Nagai K
    Clin J Gastroenterol; 2016 Feb; 9(1):17-21. PubMed ID: 26733461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.
    Kobayashi Y; Kimura K; Fujitsu Y; Shinkawa K; Muta H; Sonoda KH
    Jpn J Ophthalmol; 2016 May; 60(3):212-8. PubMed ID: 27018050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
    Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
    Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
    Toyonaga H; Fukushima M; Shimeno N; Inokuma T
    BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder.
    Sakaguchi R; Fujikawa K; Okamoto M; Matsuo E; Matsumoto K; Uchida T; Shin-Ya K; Nakashima M; Mizokami A; Kawakami A
    Intern Med; 2019 Nov; 58(21):3167-3171. PubMed ID: 31292392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate-associated Lymphoproliferative Disease with Multiple Pulmonary Nodules in a Patient with Rheumatoid Arthritis.
    Suemori K; Hasegawa H; Ishizaki J; Matsumoto T; Onishi S; Sada E; Sugita A; Yasukawa M
    Intern Med; 2015; 54(11):1421-5. PubMed ID: 26028000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial Methotrexate-Associated Lymphoproliferative Disorder in Rheumatoid Arthritis.
    Miyaza S; Matsuda R; Nakamura M; Nakagawa I; Motoyama Y; Nakase H
    World Neurosurg; 2019 Oct; 130():138-141. PubMed ID: 31295614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis.
    Yoshida Y; Takahashi Y; Yamashita H; Kano T; Kaneko H; Mimori A
    Mod Rheumatol; 2014 Sep; 24(5):763-5. PubMed ID: 24498893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
    Kameda T; Dobashi H; Miyatake N; Inoo M; Onishi I; Kurata N; Mitsunaka H; Kawakami K; Fukumoto T; Susaki K; Izumikawa M; Nakashima S; Shimada H; Takeuchi Y; Haba R; Mano S; Onishi H; Imataki O; Matsunaga T
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1302-9. PubMed ID: 24515570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Small Bowel Perforation Caused by Malignant Lymphoma after Methotrexate Therapy for Rheumatoid Arthritis].
    Tajima Y; Yabe N; Morishige S; Tamura E; Sakimoto Y; Takenoya T; Oto I; Yoshikawa T; Osumi K; Murai S
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):736-738. PubMed ID: 31164519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
    Harada T; Iwasaki H; Muta T; Urata S; Sakamoto A; Kohno K; Takase K; Miyamura T; Sawabe T; Asaoku H; Oryoji K; Fujisaki T; Mori Y; Yoshimoto G; Ayano M; Mitoma H; Miyamoto T; Niiro H; Yamamoto H; Oshiro Y; Miyoshi H; Ohshima K; Takeshita M; Akashi K; Kato K
    Br J Haematol; 2021 Jul; 194(1):101-110. PubMed ID: 33822354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.